Trials / Completed
CompletedNCT01205789
EXCEL Clinical Trial (Universal Registry)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (actual)
- Sponsor
- Abbott Medical Devices · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the Universal Registry is to assess the proportion and reasons for which subjects with angiographically significant ULMCA disease requiring revascularization during the time course of this study are not randomized; to compare the baseline characteristics of subjects; and to assess the variability in randomization eligibility and treatment patterns.
Detailed description
Approximately 100 consecutive subjects who otherwise meet all enrollment criteria, will be analyzed separately as intermediate lesion subjects, and will be followed through the time of initial treatment per standard of care with intended PCI, CABG or medical treatment.
Conditions
- Chronic Coronary Occlusion
- Left Main Coronary Artery Disease
- Stent Thrombosis
- Vascular Disease
- Myocardial Ischemia
- Coronary Artery Stenosis
- Coronary Disease
- Coronary Artery Disease
- Coronary Restenosis
Timeline
- Start date
- 2010-10-01
- Primary completion
- 2012-09-01
- Completion
- 2012-09-01
- First posted
- 2010-09-20
- Last updated
- 2012-12-04
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01205789. Inclusion in this directory is not an endorsement.